The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Can You Take Mounjaro If You Don't Have A Gallbladder?
If you've had your gallbladder removed and are considering Mounjaro (tirzepatide) for weight management, you're right to ask about safety. Having no gallbladder doesn't automatically make Mounjaro unsuitable, but it's an important factor your prescriber needs to know about. Both Mounjaro and Wegovy can affect how your digestive system works, which is relevant if you lack a gallbladder. This guide explains what you need to know before discussing prescription weight loss treatment with your GP or a licensed healthcare professional.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Mounjaro Affects Digestion and Gallbladder Function
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist that slows gastric emptying—how quickly food moves from your stomach to your small intestine. This mechanism helps reduce appetite and support weight loss. In clinical trials (SURMOUNT-1), participants on the maximum 15 mg dose lost an average of approximately 20.9% of their body weight over 72 weeks, though individual results vary significantly.
The gallbladder normally releases bile to help digest fats when you eat. When you don't have a gallbladder, bile flows continuously into your intestines rather than being released on demand. Mounjaro's effect on gastric emptying can potentially alter how bile is used and how fats are digested. Additionally, gradual weight management—which Mounjaro may support—is a known risk factor for gallstone formation in people who still have a gallbladder. For someone without one, the concern is different but still relevant to your prescriber's assessment.
- Mounjaro requires a prescription and clinical assessment
- Your gallbladder removal history must be disclosed to your prescriber
- Dose titration starts at 2.5 mg weekly and increases gradually up to 15 mg
- GLP-1 alternatives like Wegovy may be considered as options
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro vs Wegovy: Which Is Better Without A Gallbladder?
Wegovy (semaglutide) is a GLP-1 receptor agonist only—it doesn't have the dual GIP mechanism that Mounjaro has. In clinical trials (STEP-1), participants on 2.4 mg lost an average of approximately 14.9% of body weight. Both medications slow gastric emptying, so neither eliminates digestive concerns for someone without a gallbladder.
The choice between Mounjaro and Wegovy when you lack a gallbladder depends on individual factors—not one being universally "safer." Your prescriber will assess your specific health history, current symptoms (such as diarrhoea or digestive discomfort), and whether the benefits outweigh any potential risks. Some people without gallbladders tolerate GLP-1 treatment well; others experience increased digestive symptoms. Using our GLP-1 weight loss calculator can help you understand potential outcomes, but your prescriber's personalised assessment is essential. Both medications require a prescription following a clinical evaluation on the NHS or through a licensed private prescriber.
- Both slow gastric emptying—neither is risk-free without a gallbladder
- Individual tolerance varies significantly
- Your GP or prescriber makes the final suitability decision
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is Mounjaro safe if you've had a gallbladder removed?
Mounjaro may be suitable, but it requires careful assessment by your prescriber. Having no gallbladder changes how you digest fats and how you may respond to medications that slow digestion. Disclose your gallbladder removal history during your clinical assessment. Your prescriber will weigh the benefits of weight loss against any digestive risks specific to you.
What digestive side effects might Mounjaro cause without a gallbladder?
Common Mounjaro side effects include nausea, diarrhoea, constipation, and stomach pain. Without a gallbladder, you may be more sensitive to these symptoms or experience altered fat digestion. Some people report worsening digestive issues; others tolerate treatment well. Report any new or worsening symptoms to your prescriber promptly.
Should I choose Wegovy instead of Mounjaro if I don't have a gallbladder?
Not necessarily. Both Mounjaro and Wegovy affect gastric emptying and digestion. Wegovy (semaglutide) is a GLP-1 only—not dual GIP+GLP-1 like Mounjaro—but this doesn't make it automatically safer without a gallbladder. Your prescriber will assess which option (if any) suits your individual health profile best.
What should I tell my prescriber about my gallbladder removal?
Provide your medical history: when your gallbladder was removed, why, any complications, and how you've felt digestively since. Mention any ongoing digestive symptoms like diarrhoea, constipation, or fat intolerance. This information helps your prescriber decide if Mounjaro, Wegovy, or another approach is most appropriate for you.
Can I use the BMI calculator to check if I'm eligible for Mounjaro?
Yes—use our free BMI calculator to see your current BMI and healthy weight range. Eligibility for prescription weight loss treatment typically requires a BMI of 30 or above (or 27+ with health conditions). However, your gallbladder history and individual clinical assessment determine suitability, not BMI alone.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.